Fuji Pharma Co., Ltd.

TSE:4554 Voorraadrapport

Marktkapitalisatie: JP¥36.6b

Fuji Pharma Beheer

Beheer criteriumcontroles 1/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Shuhei Morita

Algemeen directeur

n/a

Totale compensatie

Percentage CEO-salarisn/a
Dienstverband CEOless than a year
Eigendom CEO0.006%
Management gemiddelde ambtstermijngeen gegevens
Gemiddelde ambtstermijn bestuur4.4yrs

Recente managementupdates

Recent updates

Impressive Earnings May Not Tell The Whole Story For Fuji Pharma (TSE:4554)

Nov 20
Impressive Earnings May Not Tell The Whole Story For Fuji Pharma (TSE:4554)

Lacklustre Performance Is Driving Fuji Pharma Co., Ltd.'s (TSE:4554) 27% Price Drop

Aug 05
Lacklustre Performance Is Driving Fuji Pharma Co., Ltd.'s (TSE:4554) 27% Price Drop

Fuji Pharma's (TSE:4554) Shareholders Will Receive A Bigger Dividend Than Last Year

Jul 22
Fuji Pharma's (TSE:4554) Shareholders Will Receive A Bigger Dividend Than Last Year

Fuji Pharma (TSE:4554) Is Increasing Its Dividend To ¥22.50

Jul 03
Fuji Pharma (TSE:4554) Is Increasing Its Dividend To ¥22.50

Fuji Pharma (TSE:4554) Has Announced That It Will Be Increasing Its Dividend To ¥22.50

Jun 19
Fuji Pharma (TSE:4554) Has Announced That It Will Be Increasing Its Dividend To ¥22.50

Impressive Earnings May Not Tell The Whole Story For Fuji Pharma (TSE:4554)

May 21
Impressive Earnings May Not Tell The Whole Story For Fuji Pharma (TSE:4554)

Fuji Pharma (TSE:4554) Will Pay A Larger Dividend Than Last Year At ¥22.50

May 13
Fuji Pharma (TSE:4554) Will Pay A Larger Dividend Than Last Year At ¥22.50

Fuji Pharma's (TSE:4554) Dividend Will Be ¥20.00

Feb 28
Fuji Pharma's (TSE:4554) Dividend Will Be ¥20.00

CEO

Shuhei Morita (50 yo)

less than a year

Tenure

Shuhei Morita serves as President & CEO of Fuji Pharma Co., Ltd. from 2024. Shuhei Morita was Director of Fuji Pharma Co., Ltd.from December 2023 until 2024. Shuhei Morita joined the Fuji Pharma Co., Ltd....

Bestuursleden

NaamPositieTenureCompensatieEigendom
Toyoyuki Kamide
VP, Executive Officer & Directorno datageen gegevens0.079%
¥ 29.0m
Fujiaki Mimura
Outside Audit & Supervisory Board Member20.9yrsgeen gegevens0.030%
¥ 11.2m
Satoshi Suzuki
Vice President & Director1.9yrsgeen gegevens0.00019%
¥ 69.6k
Keiji Hirai
Independent Outside Director7.9yrsgeen gegevens0.021%
¥ 7.8m
Minesaburo Miyake
Independent Outside Director6.9yrsgeen gegevens0.021%
¥ 7.8m
Takayuki Iwai
Representative Chairmanless than a yeargeen gegevens0.042%
¥ 15.4m
Miori Sagara
Outside Audit & Supervisory Board Member4.9yrsgeen gegevens0.0045%
¥ 1.7m
Keiko Kiyama
Independent Outside Director3.9yrsgeen gegevens0.0021%
¥ 754.8k
Yukiko Araki
Independent Outside Director3.9yrsgeen gegevens0.00082%
¥ 300.4k
Daiji Ojima
Audit & Supervisory Board Chairmanno datageen gegevens0.033%
¥ 12.1m

4.4yrs

Gemiddelde duur

62.5yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van 4554 wordt beschouwd als ervaren (gemiddelde ambtstermijn 4.4 jaar).